What is Alamar Biosciences 's change in AP?

Alamar Biosciences (ALMR) reported change in AP of $1.34M in Q1 2026.

What does change in AP mean?

Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.

Alamar Biosciences ALMR Change in AP

Change in AP at other companies

ToastTOST

$18M+80.0%

BrightSpring Health Services, Inc.BTSG

-$86.99M-61.5%

Core Scientific, Inc.CORZ

$5.87M+141%

Rexford Industrial RealtyREXR

$14.64M+47.2%

Dycom IndustriesDY

$169.39M+314%

AGNC Investment Corp.AGNC

$33M-23.3%

Other financials

Income statement

See full

Revenue$26.0M+98.9%

Gross profit$14.5M+126%

Operating income-$12.3M-44.4%

Net income-$21.3M-178%

EPS (diluted)-$1.74-156%

Balance sheet

See full

Cash & equivalents$64.6M—

Total debt$30.6M—

Total equity-$178.1M—

Total assets$186.5M—

Cash flow

See full

Operating cash flow-$20.3M-55.7%

CapEx$600.0K+8.3%

Free cash flow-$20.9M-53.8%

Valuation

See full

Market cap$1.52B—

Enterprise value$1.49B—

Returns & leverage

See full

Debt / equity-0.2×—

Current ratio5.9×—

Where this comes from

Reported directly by Alamar Biosciences in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: Alamar Biosciences ’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alamar Biosciences 's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Alamar Biosciences 's change in AP?: Alamar Biosciences (ALMR) reported change in AP of $1.34M in Q1 2026.
What does change in AP mean?: Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.